In the article by Olsen et al entitled “Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC),” which appeared in the September 15, 2007, issue of Blood (Volume 110:1713–1722), the sentence on page 1717, first column, should read, “Conversely, the Dutch system uses the diameter (> 7.5 μm) of the nuclei of cerebriform mononuclear cells to define abnormal (neoplastic) cells, and if present, this constitutes early involvement (Grade 2).58” This is in accord with what is written in Table 5.
© 2008 by The American Society of Hematology
2008
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal